# ARKG holdings: all 34 positions

> All 34 ARKG holdings with weights, as of Oct 14, 2026. The top 3 are TXG 8.97%, TWST 8.57% and TEM 8.42%. Download the full list as a CSV.

Data as of Oct 14, 2026. Rebuilt every trading night.

ARKG held 34 positions as of Oct 14, 2026. 10X Genomics Inc is the largest at 8.97%; the top 10 are 58.8% of the fund.

Source: ARK (https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | 10X Genomics Inc | TXG | 8.97% |
| 2 | Twist Bioscience Corp | TWST | 8.57% |
| 3 | Tempus AI Inc | TEM | 8.42% |
| 4 | CRISPR Therapeutics AG | CRSP | 5.54% |
| 5 | Illumina Inc | ILMN | 5.04% |
| 6 | Guardant Health Inc | GH | 4.93% |
| 7 | Natera Inc | NTRA | 4.89% |
| 8 | Absci Corp | ABSI | 4.64% |
| 9 | Eli Lilly & Co | LLY | 3.96% |
| 10 | CareDx Inc | CDNA | 3.82% |
| 11 | Veracyte Inc | VCYT | 3.39% |
| 12 | Beam Therapeutics Inc | BEAM | 3.36% |
| 13 | Schrodinger Inc/United States | SDGR | 2.82% |
| 14 | Compass Pathways Plc | CMPS | 2.76% |
| 15 | Recursion Pharmaceuticals Inc | RXRX | 2.76% |
| 16 | Nurix Therapeutics Inc | NRIX | 2.67% |
| 17 | Adaptive Biotechnologies Corp | ADPT | 2.35% |
| 18 | Personalis Inc | PSNL | 2.12% |
| 19 | Butterfly Network Inc | BFLY | 1.87% |
| 20 | Ionis Pharmaceuticals Inc | IONS | 1.87% |
| 21 | GeneDx Holdings Corp | WGS | 1.77% |
| 22 | Intellia Therapeutics Inc | NTLA | 1.71% |
| 23 | Arcturus Therapeutics Holdings Inc | ARCT UQ | 1.57% |
| 24 | Alamar Biosciences Inc | ALMR | 1.42% |
| 25 | Prime Medicine Inc | PRME | 1.21% |
| | Cash and other net assets | | 0.02% |

The largest 25 of 34 positions are shown. All of them: https://etfiq.com/funds/arkg/holdings/arkg-holdings.csv (CSV) or https://etfiq.com/data/books/arkg.json (JSON).

Fund page: https://etfiq.com/funds/arkg

Cite: ETFIQ, Holdings of ARKG, data as of Oct 14, 2026. https://etfiq.com/funds/arkg/holdings/